Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocking the enzymes
necessary for their growth. Drugs used in chemotherapy, such as gemcitabine, work in
different ways to stop tumor cells from dividing so they stop growing or die. Combining
pemetrexed disodium with gemcitabine may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining pemetrexed disodium with
gemcitabine in treating patients who have advanced cancer of the urothelium.